SHUKRA PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.2 INR | -1.97% |
|
-9.53% | +252.97% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Shukra Pharmaceuticals Limited is an India-based company, which is engaged primarily in the business of manufacturing and marketing of pharmaceutical products. The Company operates in two sectors: pharmaceutical and laboratory. The Company's manufacturing plant is situated in Rakanpur, Gandhinagar. The Company's product portfolio includes antibiotics (penicillin), anti-biotics (cephalosporin), anti-biotics, macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, analgesic (NASID), muscle relaxants, anti-tuberculosis, vitamin products, anti-allergic, corticosteroids, hyper and hypoglycemic. The Company is engaged in manufacturing general formulations, such as tablets, capsules and small volume parenteral.
Sector
Pharmaceuticals
Calendar
2024-08-01
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +252.97% | 58.52M | |
| +20.70% | 43.77B | |
| +30.16% | 22.83B | |
| +18.68% | 14.34B | |
| +54.86% | 12.96B | |
| -0.05% | 6.79B | |
| -11.72% | 6.41B | |
| -8.87% | 5.73B | |
| +14.65% | 5.69B | |
| +9.49% | 4.75B |
- Stock Market
- Equities
- SHUKRAPHAR6 Stock
- News Shukra Pharmaceuticals Limited
- Shukra Pharmaceuticals to Raise Up to $2.4 Million from Equity Offering
